City File: Boots stepping out on the offensive
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.BOOTS paid through the nose when it acquired Ward White, the Halfords and Payless DIY owner, four years ago. The chemist retailers' shares have been suffering ever since. But so confident is Boots that it has at last turned the corner - at least as far as Halfords is concerned - that 50 analysts and fund managers will be taken on a fact-finding tour around one of the car maintenance chain's branches tomorrow.
After a presentation at the Birmingham Motorcycle Museum, they will visit a nearby Halfords superstore. While the high-street outlets are doing relatively well, Halfords' out-of- town superstores, which include service centres, have been faring badly. Clearly Boots must feel that at long last it has got them to work. Boots is also going on the offensive this week with Manoplax, its new heart drug. Trade journalists and analysts will be told on Wednesday just what the drug can achieve.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments